The Treatment of Anxiety and Depression with Medicinal Cannabis

Join Prof. Kylie O'Brien and Dr. Mihindu Jayasuriya as they discuss the latest scientific evidence on using medicinal cannabis to treat anxiety and depression. Dive into the roles of CBD and THC, examine two case studies, and engage in a discussion on treatment strategies.

About Webinar

"The Treatment of Anxiety and Depression with Medicinal Cannabis" will navigate through the scientific evidence surrounding the use of medicinal cannabis for treating anxiety and depression. Dr O’Brien and Dr Jayasuriya will discuss the current scientific evidence base around the use of medicinal cannabis for these conditions.

The session will also present two case studies, providing a practical perspective on treatment strategies. The aim is to clarify the types of cannabis medicines that are more appropriate for these conditions and provide a platform to discuss treatment strategies.

Learning Outcomes

Understanding Medicinal Cannabis: Gain insights into the scientific evidence surrounding the use of medicinal cannabis in treating anxiety and depression.
Practical Application: Learn practical approaches to integrating cannabis into treatment plans for anxiety and depression through case studies.
Navigating Treatment Strategies: Engage in discussions regarding treatment strategies and understand the nuances of using medicinal cannabis for mental health conditions.
Exploring Case Studies: Understand the real-world application of medicinal cannabis in treating anxiety and depression through detailed case studies.

Dr Kylie O’Brien, Chief Scientific Officer of Cannim Group Pty Ltd, is an international expert on medicinal cannabis with a robust academic career in Chinese medicine. She has been a pivotal figure in Australia’s medicinal cannabis education and has authored books such as “Medicinal Cannabis and CBD in Mental Healthcare” and “A Clinician’s Guide to Integrative Oncology: What You Should Be Talking About with Cancer Patients and Why”.

In 2022, Kylie led an observational study investigating the effectiveness and safety of medicinal cannabis in Australians and has been a member of various committees and panels related to complementary medicines and education.

Dr Mihindu Jayasuriya, a graduate of Deakin University, has worked in various subsurgical specialties and spent considerable time in intensive care medicine and anaesthetics at The Royal Melbourne Hospital. He transitioned to working at Releaf Clinics due to his passion for cannabinoid medicine, where he is an Authorised Prescriber with the TGA for Medicinal Cannabis Products and serves as Chief Medical Officer (CMO) at Releaf Group Limited.

On-demand Webinar

Subscribe to our Free Plan and gain access to this on-demand webinar plus four more, at no cost.

Webinar details

Claim 1 CPD hour

1 hour of recorded content

Statement of Attendance

Claim 1 CPD Hour

Medihuanna is a CPD approved education provider, and this activity has been approved by the RACGP (Activity ID: 546297). Upon completing this activity, you will be eligible to claim CPD hours. The activity will include the following CPD allocation which will be uploaded to the RACGP dashboard.